6-amino-1-hydroxyhexane-1,1-diphosphonate has been researched along with hydroxyproline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beneton, MN; Galloway, J; Harris, S; Kanis, JA; McCloskey, EV; Yates, AJ | 1 |
| Bulleri, M; Di Munno, O; Giordani, R; Mazzantini, M; Metelli, MR | 1 |
1 trial(s) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and hydroxyproline
| Article | Year |
|---|---|
Single infusion of neridronate (6-amino-1-hydroxyhexylidene-1,1-bisphosphonate) in patients with active rheumatoid arthritis: effects on disease activity and bone resorption markers.
Topics: Aged; Amino Acids; Arthritis, Rheumatoid; Biomarkers; Blood Sedimentation; Bone Resorption; C-Reactive Protein; Collagen; Collagen Type I; Diphosphonates; Double-Blind Method; Female; Humans; Hydroxyproline; Male; Middle Aged; Peptides | 2002 |
1 other study(ies) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and hydroxyproline
| Article | Year |
|---|---|
Comparative effects of intravenous diphosphonates on calcium and skeletal metabolism in man.
Topics: Alkaline Phosphatase; Biopsy; Bone and Bones; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Humans; Hydroxyproline; Infusions, Intravenous; Male; Organophosphonates; Paget Disease, Extramammary; Time Factors | 1987 |